LOGIN
Addition of bone marrow aspirate to TCP show no benefit in radiographic outcomes
March 2013
Addition of bone marrow aspirate to TCP show no benefit in radiographic outcomes
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Ultraporous B-Tricalcium Phosphate Alone or Combined with Bone Marrow Aspirate for Benign Cavitary Lesions: Comparison in a Prospective Randomized Clinical Trial
J Bone Joint Surg Am. 2013 Jan 16;95(2):158-66. doi: 10.2106/JBJS.K.00181Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
55 patients were randomized to evaluate the healing of cavity defects filled with ultraporous B-tricalcium phosphate (TCP) versus TCP and bone marrow aspirate (TCP/BM). Patients with a benign bone lesion received either TCP or TCP/BM and were assessed at 24 months. Results revealed that while significant improvements in radiographic parameters were reported in both groups, the addition of BM did n...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.